Volume 16, Issue 18
Full Paper

Nanoparticle‐Based Platform for Activatable Fluorescence Imaging and Photothermal Ablation of Endometriosis

Abraham S. Moses

College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, OR, 97201 USA

Search for more papers by this author
Olena R. Taratula

College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, OR, 97201 USA

Search for more papers by this author
Hyelim Lee

College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, OR, 97201 USA

Search for more papers by this author
Fangzhou Luo

Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR, 97006 USA

Search for more papers by this author
Tanner Grenz

Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR, 97006 USA

Search for more papers by this author
Tetiana Korzun

College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, OR, 97201 USA

Search for more papers by this author
Anna St Lorenz

College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, OR, 97201 USA

Search for more papers by this author
Fahad Y. Sabei

College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, OR, 97201 USA

Search for more papers by this author
Shay Bracha

Carlson College of Veterinary Medicine, Oregon State University, 700 SW 30th Street, Corvallis, OR, 97331 USA

Search for more papers by this author
Adam W. G. Alani

College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, OR, 97201 USA

Search for more papers by this author
Ov D. Slayden

Corresponding Author

Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR, 97006 USA

E‐mail: slaydeno@ohsu.edu, oleh.taratula@oregonstate.edu

Search for more papers by this author
Oleh Taratula

Corresponding Author

College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, OR, 97201 USA

E‐mail: slaydeno@ohsu.edu, oleh.taratula@oregonstate.edu

Search for more papers by this author
First published: 06 April 2020
Citations: 3

Abstract

Endometriosis is a painful disorder where endometrium‐like tissue forms lesions outside of the uterine cavity. Intraoperative identification and removal of these lesions are difficult. This study presents a nanoplatform that concurrently delineates and ablates endometriosis tissues using real‐time near‐infrared (NIR) fluorescence and photothermal therapy (PTT). The nanoplatform consists of a dye, silicon naphthalocyanine (SiNc), capable of both NIR fluorescence imaging and PTT, and a polymeric nanoparticle as a SiNc carrier to endometriosis tissue following systemic administration. To achieve high contrast during fluorescence imaging of endometriotic lesions, nanoparticles are constructed to be non‐fluorescent prior to internalization by endometriosis cells. In vitro studies confirm that these nanoparticles activate the fluorescence signal following internalization in macaque endometrial stromal cells and ablate them by increasing cellular temperature to 53 °C upon interaction with NIR light. To demonstrate in vivo efficiency of the nanoparticles, biopsies of endometrium and endometriosis from rhesus macaques are transplanted into immunodeficient mice. Imaging with the intraoperative Fluobeam 800 system reveals that 24 h following intravenous injection, nanoparticles efficiently accumulate in, and demarcate, endometriotic grafts with fluorescence. Finally, the nanoparticles increase the temperature of endometriotic grafts up to 47 °C upon exposure to NIR light, completely eradicating them after a single treatment.

Number of times cited according to CrossRef: 3

  • Nanotechnology in reproductive medicine: Opportunities for clinical translation, Clinical and Experimental Reproductive Medicine, 10.5653/cerm.2020.03650, 47, 4, (245-262), (2020).
  • Systemically Delivered Magnetic Hyperthermia for Prostate Cancer Treatment, Pharmaceutics, 10.3390/pharmaceutics12111020, 12, 11, (1020), (2020).
  • Novel drug delivery methods for improving efficacy of endometriosis treatments, Expert Opinion on Drug Delivery, 10.1080/17425247.2021.1829589, (2020).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.